Clinical trial
Assessing the Use of Electronic Cigarettes (E-cigarettes) as a Harm Reduction Strategy
NCT02628964 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessing the Use of Electronic Cigarettes (E-cigarettes) as a Harm Reduction Strategy
- Lead sponsor
- NYU Langone Health
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2015
- Completion date
- March 26, 2018
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
smoking, tobacco use disorder